COSMOS Pharmaceutical Corporation(JP:3349)
¥6,236.00-81.00 (-1.28%)
JP:3349
COSMOS Pharmaceutical Corporation financials statements
¥6,236.00
At close:-81.00 (-1.28%)
Want to see JP:3349 full AI Analyst Report?
COSMOS Pharmaceutical Corporation (3349) Ratios
1 Followers
COSMOS Pharmaceutical Corporation Ratios
JP:3349's free cash flow for Q1 2027 was ¥0.00. For the 2027 fiscal year, JP:3349's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
| Ratios | May 26 | May 25 | May 24 | May 23 | May 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.77 | 0.75 | 0.72 | 0.71 | 0.71 |
| Quick Ratio | 0.36 | 0.33 | 0.32 | 0.31 | 0.30 |
| Cash Ratio | 0.25 | 0.26 | 0.25 | 0.24 | 0.23 |
| Solvency Ratio | 0.18 | 0.20 | 0.18 | 0.20 | 0.22 |
| Operating Cash Flow Ratio | 0.24 | 0.24 | 0.25 | 0.29 | 0.34 |
| Short-Term Operating Cash Flow Coverage | 5.20 | 9.23 | 11.45 | 20.13 | 39.25 |
| Net Current Asset Value | ¥ -127.87B | ¥ -102.08B | ¥ -90.77B | ¥ -72.81B | ¥ -57.07B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.13 | 0.10 | 0.07 | 0.04 | 0.03 |
| Debt-to-Equity Ratio | 0.28 | 0.19 | 0.15 | 0.09 | 0.05 |
| Debt-to-Capital Ratio | 0.22 | 0.16 | 0.13 | 0.08 | 0.05 |
| Long-Term Debt-to-Capital Ratio | 0.18 | 0.13 | 0.09 | 0.05 | 0.02 |
| Financial Leverage Ratio | 2.10 | 2.04 | 2.06 | 1.99 | 1.91 |
| Debt Service Coverage Ratio | 4.57 | 9.01 | 9.50 | 14.76 | 26.63 |
| Interest Coverage Ratio | 72.90 | 159.07 | 318.19 | 590.75 | 573.00 |
| Debt to Market Cap | 0.16 | 0.06 | 0.06 | 0.02 | 0.01 |
| Interest Debt Per Share | 997.48 | 633.52 | 431.12 | 230.46 | 119.51 |
| Net Debt to EBITDA | 0.26 | -0.11 | -0.34 | -0.55 | -0.58 |
| Profitability Margins | |||||
| Gross Profit Margin | 20.89% | 21.09% | 19.51% | 20.38% | 20.05% |
| EBIT Margin | 3.81% | 4.21% | 3.50% | 3.97% | 4.38% |
| EBITDA Margin | 6.05% | 6.41% | 5.57% | 6.06% | 6.38% |
| Operating Profit Margin | 3.85% | 3.99% | 3.26% | 3.64% | 3.94% |
| Pretax Profit Margin | 4.02% | 4.19% | 3.49% | 3.96% | 4.37% |
| Net Profit Margin | 2.91% | 3.06% | 2.53% | 2.88% | 3.07% |
| Continuous Operations Profit Margin | 2.91% | 3.06% | 2.53% | 2.88% | 3.07% |
| Net Income Per EBT | 72.47% | 73.11% | 72.52% | 72.61% | 70.06% |
| EBT Per EBIT | 104.40% | 104.87% | 107.04% | 108.78% | 110.91% |
| Return on Assets (ROA) | 5.37% | 5.90% | 5.13% | 5.65% | 6.38% |
| Return on Equity (ROE) | 11.30% | 12.03% | 10.57% | 11.27% | 12.15% |
| Return on Capital Employed (ROCE) | 11.91% | 13.27% | 11.96% | 13.16% | 14.82% |
| Return on Invested Capital (ROIC) | 8.37% | 9.45% | 8.47% | 9.37% | 10.23% |
| Return on Tangible Assets | 5.38% | 5.90% | 5.14% | 5.66% | 6.39% |
| Earnings Yield | 6.94% | 4.43% | 4.86% | 4.53% | 4.79% |
| Efficiency Ratios | |||||
| Receivables Turnover | 54.55 | 82.63 | 79.10 | 80.98 | 88.07 |
| Payables Turnover | 4.44 | 4.51 | 4.33 | 4.07 | 4.34 |
| Inventory Turnover | 8.78 | 8.64 | 9.01 | 8.51 | 9.10 |
| Fixed Asset Turnover | 2.89 | 3.05 | 3.26 | 3.01 | 3.16 |
| Asset Turnover | 1.84 | 1.93 | 2.02 | 1.97 | 2.08 |
| Working Capital Turnover Ratio | -19.81 | -17.75 | -16.95 | -16.30 | -18.65 |
| Cash Conversion Cycle | -33.91 | -34.37 | -39.27 | -42.23 | -39.89 |
| Days of Sales Outstanding | 6.69 | 4.42 | 4.61 | 4.51 | 4.14 |
| Days of Inventory Outstanding | 41.56 | 42.22 | 40.50 | 42.91 | 40.11 |
| Days of Payables Outstanding | 82.15 | 81.00 | 84.38 | 89.65 | 84.14 |
| Operating Cycle | 48.25 | 46.64 | 45.11 | 47.42 | 44.25 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 741.76 | 661.99 | 662.13 | 696.67 | 687.32 |
| Free Cash Flow Per Share | -147.27 | -10.84 | -10.84 | -8.02 | 98.46 |
| Dividend Paid and CapEx Coverage Ratio | 0.77 | 0.90 | 0.90 | 0.91 | 1.09 |
| Capital Expenditure Coverage Ratio | 0.83 | 0.98 | 0.98 | 0.99 | 1.17 |
| Operating Cash Flow Coverage Ratio | 0.75 | 1.05 | 1.54 | 3.03 | 5.78 |
| Operating Cash Flow to Sales Ratio | 0.05 | 0.05 | 0.05 | 0.07 | 0.07 |
| Free Cash Flow Yield | -2.53% | -0.12% | -0.17% | -0.12% | 1.61% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 14.42 | 22.60 | 20.56 | 22.07 | 20.86 |
| Price-to-Sales (P/S) Ratio | 0.42 | 0.69 | 0.52 | 0.63 | 0.64 |
| Price-to-Book (P/B) Ratio | 1.63 | 2.72 | 2.17 | 2.49 | 2.54 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -39.58 | -814.90 | -585.31 | -826.90 | 61.95 |
| Price-to-Operating Cash Flow Ratio | 7.86 | 13.34 | 9.58 | 9.52 | 8.88 |
| Price-to-Earnings Growth (PEG) Ratio | 4.18 | 0.85 | 7.60 | 7.95 | -1.42 |
| Enterprise Value Multiple | 7.21 | 10.68 | 9.02 | 9.91 | 9.44 |
| Enterprise Value | 479.12B | 692.92B | 484.54B | 497.36B | 455.16B |
| EV to EBITDA | 7.21 | 10.68 | 9.02 | 9.91 | 9.44 |
| EV to Sales | 0.44 | 0.69 | 0.50 | 0.60 | 0.60 |
| EV to Free Cash Flow | -41.05 | -806.66 | -564.07 | -783.24 | 58.37 |
| EV to Operating Cash Flow | 8.15 | 13.21 | 9.24 | 9.01 | 8.36 |
| Tangible Book Value Per Share | 3567.76 | 3242.86 | 2914.49 | 2658.21 | 2399.98 |
| Shareholders’ Equity Per Share | 3579.49 | 3248.46 | 2920.77 | 2665.11 | 2405.44 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.28 | 0.27 | 0.27 | 0.27 | 0.30 |
| Revenue Per Share | 13873.64 | 12760.89 | 12178.05 | 10450.98 | 9538.30 |
| Net Income Per Share | 404.33 | 390.86 | 308.61 | 300.47 | 292.37 |
| Tax Burden | 0.72 | 0.73 | 0.73 | 0.73 | 0.70 |
| Interest Burden | 1.06 | 0.99 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.17 | 0.15 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.83 | 1.69 | 1.69 | 2.26 | 2.29 |
Currency in JPY
